Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parkinson's Disease

  Free Subscription


Articles published in Neurosci Lett

Retrieve available abstracts of 167 articles:
HTML format
Text format



Single Articles


    November 2019
  1. CHEN W, Yan X, Lv H, Liu Y, et al
    Gender differences in prevalence of LRRK2-associated Parkinson diseaseA meta-analysis of observational studies.
    Neurosci Lett. 2019 Nov 4:134609. doi: 10.1016/j.neulet.2019.134609.
    PubMed     Text format     Abstract available


    October 2019
  2. ZHANG Y, Chen J, Xu C, Feng J, et al
    Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson's disease dementia: a meta-analysis.
    Neurosci Lett. 2019 Oct 28:134544. doi: 10.1016/j.neulet.2019.134544.
    PubMed     Text format     Abstract available


  3. IWAOKA K, Otsuka C, Maeda T, Yamahara K, et al
    Impaired metabolism of kynurenine and its metabolites in CSF of Parkinson's disease.
    Neurosci Lett. 2019 Oct 22:134576. doi: 10.1016/j.neulet.2019.134576.
    PubMed     Text format     Abstract available


  4. FINE JM, Stroebel BM, Faltesek KA, Terai K, et al
    Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease.
    Neurosci Lett. 2019;714:134567.
    PubMed     Text format     Abstract available


    September 2019
  5. SHARMA S, Awasthi A, Singh S
    Altered Gut Microbiota and Intestinal Permeability in Parkinson's disease: Pathological highlight to Management.
    Neurosci Lett. 2019 Sep 24:134516. doi: 10.1016/j.neulet.2019.134516.
    PubMed     Text format     Abstract available


    August 2019
  6. TEJERA-PARRADO C, Jesus S, Perinan MT, Buiza-Rueda D, et al
    A replication study of GWAS-genetic risk variants associated with Parkinson's disease in a Spanish population.
    Neurosci Lett. 2019 Aug 17:134425. doi: 10.1016/j.neulet.2019.134425.
    PubMed     Text format     Abstract available


  7. BANDOOKWALA M, Kumar Sahu A, Thakkar D, Sharma M, et al
    Edaravone-caffeine combination for the effective management of rotenone induced Parkinson's disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression.
    Neurosci Lett. 2019 Aug 15:134438. doi: 10.1016/j.neulet.2019.134438.
    PubMed     Text format     Abstract available


    July 2019
  8. GUIMARAES MARQUES MJ, Real CC, Balduino Victorino D, Britto LR, et al
    Endogenous protection against the 6-OHDA model of Parkinson's disease in the Amazonian rodent Proechimys.
    Neurosci Lett. 2019 Jul 17:134381. doi: 10.1016/j.neulet.2019.134381.
    PubMed     Text format     Abstract available


  9. HOU B, Zhang X, Liu Z, Wang J, et al
    Association of rs356219 and rs3822086 polymorphisms with the risk of Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2019 Jul 17:134380. doi: 10.1016/j.neulet.2019.134380.
    PubMed     Text format     Abstract available


  10. KRISHNAMOORTHY A, Sevanan M, Mani S, Balu M, et al
    Chrysin restores MPTP induced neuroinflammation, oxidative stress and neurotrophic factors in an acute Parkinson's disease mouse model.
    Neurosci Lett. 2019 Jul 17:134382. doi: 10.1016/j.neulet.2019.134382.
    PubMed     Text format     Abstract available


  11. HU F, Duan M, Peng N
    Knockdown of TRB3 improved the MPP(+)/MPTP-induced Parkinson's disease through the MAPK and AKT signaling pathways.
    Neurosci Lett. 2019;709:134352.
    PubMed     Text format     Abstract available


    June 2019
  12. MEDEIROS COSTA C, de Oliveira GL, Sousa Fonseca AC, de Carvalho Lana R, et al
    Levels of cortisol and neurotrophic factor brain-derived in Parkinson's disease.
    Neurosci Lett. 2019 Jun 29:134359. doi: 10.1016/j.neulet.2019.134359.
    PubMed     Text format     Abstract available


  13. BUARD I, Dewispelaere WD, Teale P, Rojas DC, et al
    Auditory Entrainment of Motor Responses in Older Adults with and without Parkinson's disease: an MEG study.
    Neurosci Lett. 2019 Jun 18:134331. doi: 10.1016/j.neulet.2019.134331.
    PubMed     Text format     Abstract available


  14. LI F, Wang P, Chen Z, Sui X, et al
    Alteration of the fecal microbiota in North-eastern Han Chinese population with sporadic Parkinson's disease.
    Neurosci Lett. 2019 Jun 11:134297. doi: 10.1016/j.neulet.2019.134297.
    PubMed     Text format     Abstract available


  15. HENDERSON MX, Trojanowski JQ, Lee VM
    alpha-Synuclein Pathology in Parkinson's Disease and Related alpha-Synucleinopathies.
    Neurosci Lett. 2019 Jun 3:134316. doi: 10.1016/j.neulet.2019.134316.
    PubMed     Text format     Abstract available


  16. LIU B, Luo W, Mo Y, Wei C, et al
    Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease.
    Neurosci Lett. 2019 Jun 2:134313. doi: 10.1016/j.neulet.2019.134313.
    PubMed     Text format     Abstract available


    May 2019
  17. HEMMATI-DINARVAND M, Saedi S, Valilo M, Kalantary-Charvadeh A, et al
    Oxidative stress and Parkinson's disease: conflict of oxidant-antioxidant systems.
    Neurosci Lett. 2019 May 30:134296. doi: 10.1016/j.neulet.2019.134296.
    PubMed     Text format     Abstract available


  18. DEL FABBRO L, Rossito Goes A, Jesse CR, de Gomes MG, et al
    Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson's disease.
    Neurosci Lett. 2019 May 20. pii: S0304-3940(19)30354.
    PubMed     Text format     Abstract available


  19. ZHENG J, Zang Q, Hu F, Wei H, et al
    Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.
    Neurosci Lett. 2019;706:146-150.
    PubMed     Text format     Abstract available


  20. BOROS FA, Torok R, Vagvolgyi-Sumegi E, Pesei Z, et al
    Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Neurosci Lett. 2019 May 11. pii: S0304-3940(19)30332.
    PubMed     Text format     Abstract available


  21. HU J, Xiao C, Gong D, Qiu C, et al
    Regional homogeneity analysis of major Parkinson's disease subtypes based on functional magnetic resonance imaging.
    Neurosci Lett. 2019 May 11. pii: S0304-3940(19)30331.
    PubMed     Text format     Abstract available


  22. FOLLETT J, Fox JD, Gustavsson EK, Kadgien C, et al
    DNAJC13 p.Asn855Ser, implicated in familial parkinsonism, alters membrane dynamics of Sorting Nexin 1.
    Neurosci Lett. 2019 May 10. pii: S0304-3940(19)30285.
    PubMed     Text format     Abstract available


  23. GHOSH A, Sadhukhan T, Giri S, Biswas A, et al
    Dopamine beta Hydroxylase (DBH) is a potential modifier gene associated with Parkinson's disease in Eastern India.
    Neurosci Lett. 2019 May 10. pii: S0304-3940(19)30333.
    PubMed     Text format     Abstract available


  24. DONG X, Zheng D, Nao J
    Measurement of serum cystatin C: A valuable tool for evaluating dyskinesia in Parkinson's disease.
    Neurosci Lett. 2019;705:172-176.
    PubMed     Text format     Abstract available


    April 2019
  25. FATIMA A, Rahul, Siddique YH
    Role of tangeritin against cognitive impairments in transgenic Drosophila model of Parkinson's disease.
    Neurosci Lett. 2019;705:112-117.
    PubMed     Text format     Abstract available


  26. ZHANG J, Jia G, Yang Z, Liu D, et al
    Impact of subthalamic nucleus stimulation did not differ on young-onset and older-onset Parkinson's disease: A three-year follow up.
    Neurosci Lett. 2019;705:99-105.
    PubMed     Text format     Abstract available


  27. ZHONG J, Guan X, Zhong X, Cao F, et al
    Levodopa imparts a normalizing effect on default-mode network connectivity in non-demented Parkinson's disease.
    Neurosci Lett. 2019 Apr 23. pii: S0304-3940(19)30284.
    PubMed     Text format     Abstract available


  28. MILLER S, Muqit MMK
    Therapeutic Approaches To Enhance PINK1/Parkin Mediated Mitophagy For The Treatment Of Parkinson's Disease.
    Neurosci Lett. 2019 Apr 14. pii: S0304-3940(19)30263.
    PubMed     Text format     Abstract available


  29. PAPAGIANNAKIS N, Xilouri M, Koros C, Simitsi AM, et al
    Autophagy dysfunction in peripheral blood mononuclear cells of Parkinson's disease patients.
    Neurosci Lett. 2019;704:112-115.
    PubMed     Text format     Abstract available


  30. MA LY, Gao LY, Li X, Ma HZ, et al
    Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
    Neurosci Lett. 2019 Apr 1. pii: S0304-3940(19)30226.
    PubMed     Text format     Abstract available


    March 2019
  31. SUSAN B, James R, Bonnie R, Joseph H, et al
    Neuroprotective effects of acetyl-L-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
    Neurosci Lett. 2019 Mar 16. pii: S0304-3940(19)30170.
    PubMed     Text format     Abstract available


  32. WANG L, Li NN, Lu ZJ, Li JY, et al
    Association of three candidate genetic variants in ACMSD/TMEM163, GPNMB and BCKDK /STX1B with sporadic Parkinson's disease in Han Chinese.
    Neurosci Lett. 2019 Mar 14. pii: S0304-3940(19)30173.
    PubMed     Text format     Abstract available


    February 2019
  33. WANG Z, Sun L, Jia K, Wang H, et al
    miR-9-5p modulates the progression of Parkinson's disease by targeting SIRT1.
    Neurosci Lett. 2019 Feb 28. pii: S0304-3940(19)30130.
    PubMed     Text format     Abstract available


  34. GUDUCU C, Eskicioglu E, Oz D, Oniz A, et al
    Auditory Brain Oscillatory Responses in Drug-naive Patients with Parkinson's Disease.
    Neurosci Lett. 2019 Feb 28. pii: S0304-3940(19)30131.
    PubMed     Text format     Abstract available


  35. WANG X, Shen N, Lu Y, Tan K, et al
    Vitamin D receptor polymorphisms and the susceptibility of Parkinson's disease.
    Neurosci Lett. 2019 Feb 11. pii: S0304-3940(19)30101.
    PubMed     Text format     Abstract available


  36. GUNAYDIN C, Avci B, Bozkurt A, Onger ME, et al
    Effects of Agomelatine in Rotenone-induced Parkinson's Disease in Rats.
    Neurosci Lett. 2019 Feb 1. pii: S0304-3940(19)30075.
    PubMed     Text format     Abstract available


    January 2019
  37. KAWAMURA M, Sato S, Matsumoto G, Fukuda T, et al
    Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.
    Neurosci Lett. 2019 Jan 23. pii: S0304-3940(19)30054.
    PubMed     Text format     Abstract available


    December 2018
  38. CAO Z, Wu Y, Liu G, Jiang Y, et al
    alpha-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Neurosci Lett. 2018;696:114-120.
    PubMed     Text format     Abstract available


  39. WANG S, Li N, Zou H, Wu M, et al
    Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson's disease.
    Neurosci Lett. 2018 Dec 17. pii: S0304-3940(18)30866.
    PubMed     Text format     Abstract available


  40. BUENO MEB, do Nascimento Neto LI, Terra MB, Barboza NM, et al
    Effectiveness of acute transcranial direct current stimulation on non-motor and motor symptoms in Parkinson's disease.
    Neurosci Lett. 2018;696:46-51.
    PubMed     Text format     Abstract available


  41. ALIZADEH R, Kamrava SK, Bagher Z, Farhadi M, et al
    Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.
    Neurosci Lett. 2018;696:52-59.
    PubMed     Text format     Abstract available


    November 2018
  42. ZAMPIER VC, Vitorio R, Beretta VS, Jaimes DAR, et al
    Gait bradykinesia and hypometria decrease as arm swing frequency and amplitude increase.
    Neurosci Lett. 2018;687:248-252.
    PubMed     Text format     Abstract available


  43. WANG Z, Kuang P, Lin Y, Liu W, et al
    Re-expression of voltage-gated sodium channel subtype Nav1.3 in the substantia nigra after dopamine depletion.
    Neurosci Lett. 2018;687:146-152.
    PubMed     Text format     Abstract available


  44. LEVY-GIGI E, Haim-Nahum S, Hall JM, Crouse J, et al
    The interactive effect of valence and context on reversal learning in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Nov 6. pii: S0304-3940(18)30751.
    PubMed     Text format     Abstract available


    October 2018
  45. MIRANDA-MORALES EG, Sandoval-Carrillo A, Castellanos-Juarez FX, Mendez-Hernandez EM, et al
    H1/H2 MAPT haplotype and Parkinson's Disease in Mexican mestizo population.
    Neurosci Lett. 2018 Oct 16. pii: S0304-3940(18)30705.
    PubMed     Text format     Abstract available


  46. PURCARO C, Vanacore N, Moret F, Di Battista ME, et al
    DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.
    Neurosci Lett. 2018 Oct 11. pii: S0304-3940(18)30697.
    PubMed     Text format     Abstract available


  47. SHISHIDO T, Nagano Y, Araki M, Kurashige T, et al
    Synphilin-1 has neuroprotective effects on MPP(+)-induced Parkinson's disease model cells by inhibiting ROS production and apoptosis.
    Neurosci Lett. 2018 Oct 11. pii: S0304-3940(18)30696.
    PubMed     Text format     Abstract available


  48. FONSECA-FONSECA LA, Wong-Guerra M, Ramirez-Sanchez J, Montano-Peguero Y, et al
    JM-20, a novel hybrid molecule, protects against rotenone-induced neurotoxicity in experimental model of Parkinson's disease.
    Neurosci Lett. 2018 Oct 7. pii: S0304-3940(18)30678.
    PubMed     Text format     Abstract available


    September 2018
  49. JIN L, Wan W, Wang L, Wang C, et al
    Elevated microRNA-520d-5p in the serum of patients with Parkinson's disease, possibly through regulation of cereloplasmin expression.
    Neurosci Lett. 2018 Sep 19. pii: S0304-3940(18)30640.
    PubMed     Text format     Abstract available


  50. LU J, Chen S, Shen M, He Q, et al
    Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models.
    Neurosci Lett. 2018 Sep 18. pii: S0304-3940(18)30637.
    PubMed     Text format     Abstract available


  51. CACABELOS R
    Pharmacogenomics of Alzheimer's and Parkinson's diseases.
    Neurosci Lett. 2018 Sep 17. pii: S0304-3940(18)30624.
    PubMed     Text format     Abstract available


  52. CRUZ CF, Piemonte MEP, Okai-Nobrega LA, Okamoto E, et al
    Parkinson's disease does not alter automatic visual-motor coupling in postural control.
    Neurosci Lett. 2018;686:47-52.
    PubMed     Text format     Abstract available


    August 2018
  53. CHOI DJ, Kwon JK, Joe EH
    A Parkinson's disease gene, DJ-1, regulates astrogliosis through STAT3.
    Neurosci Lett. 2018;685:144-149.
    PubMed     Text format     Abstract available


  54. CHEN Y, Cao B, Chen X, Ou R, et al
    The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Neurosci Lett. 2018 Aug 22. pii: S0304-3940(18)30569.
    PubMed     Text format     Abstract available


    July 2018
  55. LI D, Song X, Huang H, Huang H, et al
    Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-alpha.
    Neurosci Lett. 2018 Jul 28. pii: S0304-3940(18)30500.
    PubMed     Text format     Abstract available


  56. GE F, Ding J, Liu Y, Lin H, et al
    Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: a meta-analysis.
    Neurosci Lett. 2018 Jul 20. pii: S0304-3940(18)30503.
    PubMed     Text format     Abstract available


  57. ROSAS-HERNANDEZ H, Chigurupati S, Raymick J, Robinson B, et al
    Identification of altered microRNAs in serum of a mouse model of Parkinson's disease.
    Neurosci Lett. 2018;687:1-9.
    PubMed     Text format     Abstract available


  58. SI QQ, Yuan YS, Zhi Y, Tong Q, et al
    Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
    Neurosci Lett. 2018;684:42-46.
    PubMed     Text format     Abstract available


    June 2018
  59. MARTIN-RODRIGUEZ JF, Mir P
    Short-afferent inhibition and cognitive impairment in Parkinson's disease: A Quantitative Review and Challenges.
    Neurosci Lett. 2018 Jun 27. pii: S0304-3940(18)30451.
    PubMed     Text format     Abstract available


  60. SHEN YT, Li JY, Yuan YS, Wang XX, et al
    Disrupted amplitude of low-frequency fluctuations and causal connectivity in Parkinson's disease with apathy.
    Neurosci Lett. 2018;683:75-81.
    PubMed     Text format     Abstract available


  61. LUCA A, Nicoletti A, Mostile G, Sciacca G, et al
    Temperament Traits And Executive Functions In Parkinson's Disease.
    Neurosci Lett. 2018 Jun 22. pii: S0304-3940(18)30443.
    PubMed     Text format     Abstract available


  62. LUOMA J, Pekkonen E, Airaksinen K, Helle L, et al
    Spontaneous sensorimotor cortical activity is suppressed by deep brain stimulation in patients with advanced Parkinson's disease.
    Neurosci Lett. 2018 Jun 22. pii: S0304-3940(18)30444.
    PubMed     Text format     Abstract available


  63. KWIATEK-MAJKUSIAK J, Geremek M, Koziorowski D, Tomasiuk R, et al
    Higher serum levels of pro-hepcidin in patients with Parkinson's disease treated with deep brain stimulation.
    Neurosci Lett. 2018 Jun 18. pii: S0304-3940(18)30434.
    PubMed     Text format     Abstract available


  64. DU G, Zhuang P, Zhang Y, Li J, et al
    Neuronal firing rate and oscillatory patterns in the basal ganglia nuclei differ from those of the ventrolateral thalamus in patients with Parkinson disease.
    Neurosci Lett. 2018;683:1-6.
    PubMed     Text format     Abstract available


  65. PING Z, Xiaomu W, Xufang X, Wenfeng C, et al
    GAPDH rs1136666 SNP indicates a high risk of Parkinson's disease.
    Neurosci Lett. 2018 Jun 7. pii: S0304-3940(18)30416.
    PubMed     Text format     Abstract available


  66. NAGARAJAN VB, Marathe PA
    Effect of montelukast in experimental model of Parkinson's disease.
    Neurosci Lett. 2018 Jun 6. pii: S0304-3940(18)30403.
    PubMed     Text format     Abstract available


    May 2018
  67. SHU L, Zhang Y, Sun Q, Pan H, et al
    SNCA REP1 and Parkinson's disease.
    Neurosci Lett. 2018 May 30. pii: S0304-3940(18)30394.
    PubMed     Text format     Abstract available


  68. KUMARI N, Agrawal S, Kumari R, Sharma D, et al
    Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
    Neurosci Lett. 2018;675:74-82.
    PubMed     Text format     Abstract available


  69. ZHANG S, Chen S, Liu A, Wan J, et al
    Inhibition of BDNF production by MPP(+) through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model.
    Neurosci Lett. 2018;675:133-139.
    PubMed     Text format     Abstract available


  70. POWELL DW, Blackmore SE, Puppa M, Lester D, et al
    Deep brain stimulation enhances movement complexity during gait in individuals with Parkinson's disease.
    Neurosci Lett. 2018 May 8. pii: S0304-3940(18)30337.
    PubMed     Text format     Abstract available


  71. BEGUM M ET, Sen D
    DOR agonist (SNC-80) exhibits anti-parkinsonian effect via downregulating UPR/oxidative stress signals and inflammatory response in vivo.
    Neurosci Lett. 2018;678:29-36.
    PubMed     Text format     Abstract available


    April 2018
  72. FANG L, Tang BS, Fan K, Wan CM, et al
    Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.
    Neurosci Lett. 2018 Apr 23. pii: S0304-3940(18)30305.
    PubMed     Text format     Abstract available


  73. PUPYSHEV AB, Korolenko TA, Akopyan AA, Amstislavskaya TG, et al
    Suppression of autophagy in the brain of transgenic mice with overexpression of capital A, Cyrillic53capital TE, Cyrillic-mutant alpha-synuclein as an early event at synucleinopathy progression.
    Neurosci Lett. 2018;672:140-144.
    PubMed     Text format     Abstract available


  74. WANG P, Guo Y, Song C, Liu Y, et al
    PINK1 p.K520RfsX3 Mutation Identified in a Chinese Family with Early-onset Parkinson's disease.
    Neurosci Lett. 2018 Apr 12. pii: S0304-3940(18)30283.
    PubMed     Text format     Abstract available


  75. SHEEHAN P, Yue Z
    Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
    Neurosci Lett. 2018 Apr 5. pii: S0304-3940(18)30268.
    PubMed     Text format     Abstract available


  76. CHU CT
    Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson's disease.
    Neurosci Lett. 2018 Apr 4. pii: S0304-3940(18)30259.
    PubMed     Text format     Abstract available


    March 2018
  77. CROOKS SA, Bech S, Halling J, Christiansen DH, et al
    Carnitine levels and mutations in the SLC22A5 gene in Faroes patients with Parkinson's disease.
    Neurosci Lett. 2018;675:116-119.
    PubMed     Text format     Abstract available


  78. LI W, Jiang Y, Wang Y, Yang S, et al
    MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
    Neurosci Lett. 2018;675:83-88.
    PubMed     Text format     Abstract available


  79. SADHUKHAN D, Das G, Biswas A, Ghosh S, et al
    Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians.
    Neurosci Lett. 2018 Mar 28. pii: S0304-3940(18)30236.
    PubMed     Text format     Abstract available


  80. GENG L, Zhang T, Liu W, Chen Y, et al
    miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
    Neurosci Lett. 2018;675:23-30.
    PubMed     Text format     Abstract available


  81. HOU Y, Luo C, Yang J, Ou R, et al
    Altered intrinsic brain functional connectivity in drug-naive Parkinson's disease patients with LRRK2 mutations.
    Neurosci Lett. 2018 Mar 19. pii: S0304-3940(18)30215.
    PubMed     Text format     Abstract available


  82. MAPLE-GRODEM J, Chung J, Lunde KA, Tzoulis C, et al
    Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease.
    Neurosci Lett. 2018;674:123-126.
    PubMed     Text format     Abstract available


  83. WATANABE T, Saito K, Ishida K, Tanabe S, et al
    Effect of auditory stimulus on executive function and execution time during cognitively demanding stepping task in patients with Parkinson's disease.
    Neurosci Lett. 2018 Mar 17. pii: S0304-3940(18)30209.
    PubMed     Text format     Abstract available


  84. POCHMANN D, Peccin PK, da Silva IRV, Dorneles GP, et al
    Cytokine modulation in response to acute and chronic aquatic therapy intervention in Parkinson disease individuals: A pilot study.
    Neurosci Lett. 2018 Mar 11. pii: S0304-3940(18)30190.
    PubMed     Text format     Abstract available


  85. JIN H, Chen J, Li K, Zhang JR, et al
    A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson's disease in Han Chinese patients.
    Neurosci Lett. 2018 Mar 9. pii: S0304-3940(18)30186.
    PubMed     Text format     Abstract available


    February 2018
  86. GUO T, Guan X, Zeng Q, Xuan M, et al
    Correlations between CSF proteins and spontaneous neuronal activity in Parkinson's disease.
    Neurosci Lett. 2018;673:61-66.
    PubMed     Text format     Abstract available


  87. DUTTA P, Dargahi L, O'Connell KE, Bolia A, et al
    A novel modelling mechanism of PAEL receptor and GABARAPL2 interaction involved in Parkinson's disease.
    Neurosci Lett. 2018;673:12-18.
    PubMed     Text format     Abstract available


  88. DI NATALE C, Monaco A, Pedone C, Tessitore A, et al
    THE LEVEL OF 24-HYDROXYCHOLESTERYL ESTERS DECREASES IN PLASMA OF PATIENTS WITH PARKINSON'S DISEASE.
    Neurosci Lett. 2018 Feb 24. pii: S0304-3940(18)30123.
    PubMed     Text format     Abstract available


  89. JIANG X, Wang X, Tuo M, Ma J, et al
    RAGE and its emerging role in the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2018 Feb 22. pii: S0304-3940(18)30131.
    PubMed     Text format     Abstract available


  90. ZHENG X, Chen X, Guo M, Ali S, et al
    Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.
    Neurosci Lett. 2018 Feb 15. pii: S0304-3940(18)30100.
    PubMed     Text format     Abstract available


  91. GOMEZ G, Saborido MD, Bernardi MA, Gershanik OS, et al
    Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia.
    Neurosci Lett. 2018;666:5-10.
    PubMed     Text format     Abstract available


  92. SILVEIRA CRA, Roy EA, Almeida QJ
    Acute effects of aerobic exercise on cognitive function in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Feb 3. pii: S0304-3940(18)30068.
    PubMed     Text format     Abstract available


    January 2018
  93. MAO W, Zhao C, Ding H, Liang K, et al
    Pyrosequencing analysis of methylation levels of clock genes in leukocytes from Parkinson's disease patients.
    Neurosci Lett. 2018;668:115-119.
    PubMed     Text format     Abstract available


  94. WANG X, Li J, Wang M, Yuan Y, et al
    Alterations of the amplitude of low-frequency fluctuations in anxiety in Parkinson's disease.
    Neurosci Lett. 2018;668:19-23.
    PubMed     Text format     Abstract available


  95. MOON HC, Won SY, Kim EG, Kim HK, et al
    Effect of optogenetic modulation on entopeduncular input affects thalamic discharge and behavior in an AAV2-alpha-synuclein-induced hemiparkinson rat model.
    Neurosci Lett. 2018;662:129-135.
    PubMed     Text format     Abstract available


  96. ZHENG Q, Huang C, Guo J, Tan J, et al
    Hsp70 participates in PINK1-mediated mitophagy by regulating the stability of PINK1.
    Neurosci Lett. 2018;662:264-270.
    PubMed     Text format     Abstract available


    December 2017
  97. SEKAR S, Taghibiglou C
    Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease.
    Neurosci Lett. 2017;666:139-143.
    PubMed     Text format     Abstract available


  98. WANG L, Nie K, Zhao X, Feng S, et al
    Characteristics of gray matter morphological change in Parkinson's disease patients with semantic abstract reasoning deficits.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31020.
    PubMed     Text format     Abstract available


  99. CHENG Y, Mao CY, Liu YT, Li F, et al
    Analysis of variant rs3794087 in SLC1A2 and Parkinson's disease in a Chinese Han population: a case-control study and meta-analysis.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31018.
    PubMed     Text format     Abstract available


  100. HARRISON IF, Smith AD, Dexter DT
    Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
    Neurosci Lett. 2017;666:48-57.
    PubMed     Text format     Abstract available


  101. AN C, Pu X, Xiao W, Zhang H, et al
    Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017;665:236-239.
    PubMed     Text format     Abstract available


  102. BREZA M, Koutsis G, Karadima G, Potagas C, et al
    The different faces of the p. A53T alpha-synuclein mutation: a screening of Greek patients with parkinsonism and/or dementia.
    Neurosci Lett. 2017 Dec 9. pii: S0304-3940(17)30988.
    PubMed     Text format     Abstract available


    November 2017
  103. LI XR, Ren YD, Cao B, Huang XL, et al
    Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Neurosci Lett. 2017 Nov 30. pii: S0304-3940(17)30973.
    PubMed     Text format     Abstract available


  104. DU K, Liu MY, Pan YZ, Zhong X, et al
    Association of circulating manganese levels with Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017;665:92-98.
    PubMed     Text format     Abstract available


  105. CAI M, Liu Z, Li W, Wang Y, et al
    Association between rs823128 polymorphism and the risk of Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017 Nov 27. pii: S0304-3940(17)30966.
    PubMed     Text format     Abstract available


  106. PAPAGIANNAKIS N, Koros C, Stamelou M, Simitsi AM, et al
    Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease.
    Neurosci Lett. 2017 Nov 9. pii: S0304-3940(17)30910.
    PubMed     Text format     Abstract available


  107. YUAN XQ, Cao B, Wu Y, Chen YP, et al
    Association analysis of SNP rs11868035 in SREBF1 with sporadic Parkinson's disease, sporadic amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population.
    Neurosci Lett. 2017 Nov 8. pii: S0304-3940(17)30913.
    PubMed     Text format     Abstract available


    October 2017
  108. LIU L, Zhang L, Guo L, Yu Q, et al
    MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.
    Neurosci Lett. 2017;662:339-345.
    PubMed     Text format     Abstract available


  109. WU Q, Gao Y, Liu AS, Xie LZ, et al
    Large-scale cortical volume correlation networks reveal disrupted small world patterns in Parkinson's disease.
    Neurosci Lett. 2017 Oct 20. pii: S0304-3940(17)30858.
    PubMed     Text format     Abstract available


  110. MATSUURA K, Kajikawa H, Tabei KI, Satoh M, et al
    The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson's disease.
    Neurosci Lett. 2017 Oct 12. pii: S0304-3940(17)30836.
    PubMed     Text format     Abstract available


    September 2017
  111. KONG P, Lei P, Zhang S, Li D, et al
    Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2017 Sep 28. pii: S0304-3940(17)30793.
    PubMed     Text format     Abstract available


  112. GMITTEROVA K, Gawinecka J, Heinemann U, Valkovic P, et al
    DNA versus RNA oxidation in Parkinson's disease: which is more important?
    Neurosci Lett. 2017 Sep 26. pii: S0304-3940(17)30790.
    PubMed     Text format     Abstract available


  113. ABBAOUI A, Chatoui H, Hiba OE, Gamrani H, et al
    Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
    Neurosci Lett. 2017 Sep 14. pii: S0304-3940(17)30774.
    PubMed     Text format     Abstract available


  114. XI J, Yang X, Zhao Q, Zheng J, et al
    Absence of association of the Ala58Val (rs17571) CTSD gene variant with Parkinson's disease or amyotrophic lateral sclerosis in a Han Chinese population.
    Neurosci Lett. 2017 Sep 13. pii: S0304-3940(17)30771.
    PubMed     Text format     Abstract available


  115. FLACH A, Jaegers L, Krieger M, Bixler E, et al
    Endurance Exercise Improves Function in Individuals with Parkinson's Disease: A Meta-analysis.
    Neurosci Lett. 2017 Sep 1. pii: S0304-3940(17)30733.
    PubMed     Text format     Abstract available


    August 2017
  116. CAO H, Shi J, Cao B, Kang B, et al
    Evaluation of the Braak staging of brain pathology with 1H-MRS in patients with Parkinson's disease.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30697.
    PubMed     Text format     Abstract available


  117. LINDENAU JD, Altmann V, Schumacher-Schuh AF, Rieder CR, et al
    Tumor necrosis factor alpha polymorphisms are associated with Parkinson's disease age at onset.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30696.
    PubMed     Text format     Abstract available


  118. FANG J, Hou B, Liu H, Zhang X, et al
    Association between SNCA rs2736990 polymorphism and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017;658:102-107.
    PubMed     Text format     Abstract available


  119. LUDTMANN MHR, Abramov AY
    Mitochondrial calcium imbalance in Parkinson's disease.
    Neurosci Lett. 2017 Aug 21. pii: S0304-3940(17)30691.
    PubMed     Text format     Abstract available


  120. BERGE-SEIDL V, Pihlstrom L, Maple-Grodem J, Forsgren L, et al
    The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Neurosci Lett. 2017 Aug 19. pii: S0304-3940(17)30687.
    PubMed     Text format     Abstract available


  121. GAO Y, Nie K, Huang B, Mei M, et al
    Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Neurosci Lett. 2017 Aug 17. pii: S0304-3940(17)30675.
    PubMed     Text format     Abstract available


  122. LV W, Guan Q, Hu X, Chen J, et al
    Vestibulo-ocular reflex abnormality in Parkinson's disease detected by video head impulse test.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30668.
    PubMed     Text format     Abstract available


  123. HE T, Wang J, Wang X, Deng W, et al
    Association between PARK16 and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30669.
    PubMed     Text format     Abstract available


  124. XIAO H, Li M, Cai J, Li N, et al
    Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
    Neurosci Lett. 2017 Aug 10. pii: S0304-3940(17)30663.
    PubMed     Text format     Abstract available


  125. FANG J, Chen H, Cao Z, Jiang Y, et al
    Impaired Brain Network Architecture in Newly Diagnosed Parkinson's Disease Based on Graph Theoretical Analysis.
    Neurosci Lett. 2017 Aug 5. pii: S0304-3940(17)30638.
    PubMed     Text format     Abstract available


    July 2017
  126. RINGMAN JM, Casado M, Van Berlo V, Pa J, et al
    A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30618.
    PubMed     Text format     Abstract available


  127. WEILAN Y, Weiguo Y, Baisheng H, Lixiang W, et al
    Neuroprotective Effects of Lentivirus-mediated Cystathionine-beta-synthase Overexpression against 6-OHDA-induced Parkinson's Disease Rats.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30581.
    PubMed     Text format     Abstract available


  128. LI X, Xue L, Sun J, Sun Y, et al
    Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson's disease in the North-eastern Han Chinese population.
    Neurosci Lett. 2017;656:72-76.
    PubMed     Text format     Abstract available


  129. REED-JONES RJ, Powell DW
    The effects of gaze stabilization on gait parameters in individuals with Parkinson's disease.
    Neurosci Lett. 2017 Jul 11. pii: S0304-3940(17)30573.
    PubMed     Text format     Abstract available


  130. YAO Z, Shao Y, Han X
    Freezing of gait is associated with cognitive impairment in patients with Parkinson disease.
    Neurosci Lett. 2017 Jul 8. pii: S0304-3940(17)30555.
    PubMed     Text format     Abstract available


    June 2017
  131. DIBILIO V, Nicoletti A, Mostile G, Portaro G, et al
    Computer-Assisted Cognitive Rehabilitation on Freezing of Gait in Parkinson's Disease: A Pilot Study.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30486.
    PubMed     Text format     Abstract available


  132. HE D, Hu P, Deng X, Song Z, et al
    Genetic analysis of the RIC3 gene in Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30487.
    PubMed     Text format     Abstract available


  133. WANG X, Zhang J, Yuan Y, Li T, et al
    Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
    Neurosci Lett. 2017;653:202-207.
    PubMed     Text format     Abstract available


  134. SHIN JH, Shin SA, Lee JY, Nam H, et al
    Precuneus degeneration and isolated apathy in patients with Parkinson's disease.
    Neurosci Lett. 2017;653:250-257.
    PubMed     Text format     Abstract available


    May 2017
  135. HAO Y, Shabanpoor A, Metz GA
    Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
    Neurosci Lett. 2017;651:79-87.
    PubMed     Text format     Abstract available


    April 2017
  136. PENG B, Wang S, Zhou Z, Liu Y, et al
    A multilevel-ROI-features-based machine learning method for detection of morphometric biomarkers in Parkinson's disease.
    Neurosci Lett. 2017 Apr 20. pii: S0304-3940(17)30335.
    PubMed     Text format     Abstract available


  137. LIU H, Liu H, Li T, Cui J, et al
    NR4A2 genetic variation and Parkinson's disease: evidence from a systematic review and meta-analysis.
    Neurosci Lett. 2017 Apr 3. pii: S0304-3940(17)30090.
    PubMed     Text format     Abstract available


  138. YANG X, Zheng J, An R, Tian S, et al
    Polymorphism in MIR4697 but not VPS13C, GCH1, or SIPA1L2 is associated with risk of Parkinson's disease in a Han Chinese population.
    Neurosci Lett. 2017 Apr 2. pii: S0304-3940(17)30287.
    PubMed     Text format     Abstract available


    March 2017
  139. CHEN S, Liu Y, Niu Y, Xu Y, et al
    Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients.
    Neurosci Lett. 2017 Mar 27. pii: S0304-3940(17)30275.
    PubMed     Text format     Abstract available


  140. KUMARI N, Agrawal S, Luthra PM
    Pharmacological assessments of potent A2A receptor antagonist IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo[4,5-d]pyrimidin-6(7H)-yl)urea) in rodent model of haloperidol induced Parkinson like symptoms.
    Neurosci Lett. 2017;647:53-60.
    PubMed     Text format     Abstract available


  141. DEMETER G, Valalik I, Pajkossy P, Szollosi A, et al
    The effect of deep brain stimulation of the subthalamic nucleus on executive functions: Impaired verbal fluency and intact updating, planning and conflict resolution in Parkinson's disease.
    Neurosci Lett. 2017 Mar 18. pii: S0304-3940(17)30247.
    PubMed     Text format     Abstract available


  142. WANG L, Huang J, Pang S, Qin X, et al
    Genetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease.
    Neurosci Lett. 2017;646:30-35.
    PubMed     Text format     Abstract available


    February 2017
  143. TANG Y, Meng L, Wan CM, Liu ZH, et al
    Identifying the presence of Parkinson's disease using low-frequency fluctuations in BOLD signals.
    Neurosci Lett. 2017 Feb 26. pii: S0304-3940(17)30172.
    PubMed     Text format     Abstract available


  144. CAO XY, Lu JM, Zhao ZQ, Li MC, et al
    MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Neurosci Lett. 2017 Feb 18. pii: S0304-3940(17)30161.
    PubMed     Text format     Abstract available


  145. TANAKA K, Miyake Y, Fukushima W, Kiyohara C, et al
    Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
    Neurosci Lett. 2017;643:97-102.
    PubMed     Text format     Abstract available


  146. FATHALLA AM, Soliman AM, Moustafa AA
    Selective A2A receptors blockade reduces degeneration of substantia nigra dopamine neurons in a rotenone-induced rat model of Parkinson's disease: A histological study.
    Neurosci Lett. 2017;643:89-96.
    PubMed     Text format     Abstract available


  147. MIKI Y, Tanji K, Mori F, Kakita A, et al
    PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Neurosci Lett. 2017 Feb 14. pii: S0304-3940(17)30133.
    PubMed     Text format     Abstract available


  148. LI Y, Huang J, Pang S, Wang H, et al
    Novel and functional ATG12 gene variants in sporadic Parkinson's disease.
    Neurosci Lett. 2017 Feb 13. pii: S0304-3940(17)30134.
    PubMed     Text format     Abstract available


  149. TIAN S, Yang X, Zhao Q, Zheng J, et al
    Association between a heme oxygenase-2 genetic variant and risk of Parkinson's disease in Han Chinese.
    Neurosci Lett. 2017 Feb 5. pii: S0304-3940(17)30114.
    PubMed     Text format     Abstract available


    January 2017
  150. KANG SY, Lee SB, Kim HJ, Kim HT, et al
    Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
    Neurosci Lett. 2017 Jan 27. pii: S0304-3940(17)30091.
    PubMed     Text format     Abstract available


  151. CORBILLE AG, Preterre C, Rolli-Derkinderen M, Coron E, et al
    Biochemical analysis of alpha-synuclein extracted from control and Parkinson's disease colonic biopsies.
    Neurosci Lett. 2017 Jan 23. pii: S0304-3940(17)30070.
    PubMed     Text format     Abstract available


  152. ZHANG Y, Wu JY, Weng LH, Li XX, et al
    Valproic acid protects against MPP(+)-mediated neurotoxicity in SH-SY5Y Cells through autophagy.
    Neurosci Lett. 2017;638:60-68.
    PubMed     Text format     Abstract available


  153. BRIFFA M, Ghio S, Neuner J, Gauci AJ, et al
    Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Neurosci Lett. 2017;638:12-20.
    PubMed     Text format     Abstract available


    December 2016
  154. PEZZI JC, Bem CM, Rocha TJ, Schumacher-Schuh AF, et al
    Association between DNA methyltransferase gene polymorphism and Parkinson's disease.
    Neurosci Lett. 2016 Dec 29. pii: S0304-3940(16)31006.
    PubMed     Text format     Abstract available


  155. RIAL D, Morato X, Real JI, Goncalves FQ, et al
    Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses.
    Neurosci Lett. 2016;638:162-166.
    PubMed     Text format     Abstract available


  156. XIANG Y, Gong T, Wu J, Li J, et al
    Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging.
    Neurosci Lett. 2016;638:145-150.
    PubMed     Text format     Abstract available


    November 2016
  157. XIE Y, Feng H, Peng S, Xiao J, et al
    Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2016 Nov 10. pii: S0304-3940(16)30846.
    PubMed     Text format     Abstract available


  158. LATTARI E, Costa SS, Campos C, de Oliveira AJ, et al
    Can transcranial direct current stimulation on the dorsolateral prefrontal cortex improves balance and functional mobility in Parkinson's disease?
    Neurosci Lett. 2016 Nov 9. pii: S0304-3940(16)30861.
    PubMed     Text format     Abstract available


  159. CAO CY, Zeng K, Li DY, Zhan SK, et al
    Modulations on cortical oscillations by Subthalamic deep brain stimulation in patients with Parkinson disease: a MEG study.
    Neurosci Lett. 2016 Nov 3. pii: S0304-3940(16)30848.
    PubMed     Text format     Abstract available


    October 2016
  160. PCHELINA S, Emelyanov A, Baydakova G, Andoskin P, et al
    Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
    Neurosci Lett. 2016 Oct 22. pii: S0304-3940(16)30792.
    PubMed     Text format     Abstract available


  161. ABREU GM, Valenca DC, Campos M Junior, da Silva CP, et al
    Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Neurosci Lett. 2016;635:67-70.
    PubMed     Text format     Abstract available


  162. DENG X, Tang CY, Zhang J, Zhu L, et al
    The cortical thickness correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016;633:279-289.
    PubMed     Text format     Abstract available


  163. HOU Y, Luo C, Yang J, Song W, et al
    A resting-state fMRI study on early-stage drug-naive Parkinson's disease patients with drooling.
    Neurosci Lett. 2016 Oct 4. pii: S0304-3940(16)30749.
    PubMed     Text format     Abstract available


    September 2016
  164. ZENG W, Liu F, Wang Q, Wang Y, et al
    Parkinson's disease classification using gait analysis via deterministic learning.
    Neurosci Lett. 2016 Sep 27. pii: S0304-3940(16)30726.
    PubMed     Text format     Abstract available


  165. SHI C, Li F, Yang J, Zhang S, et al
    DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2016 Sep 26. pii: S0304-3940(16)30727.
    PubMed     Text format     Abstract available


  166. DENG X, Li FJ, Tang CY, Zhang J, et al
    The cortical surface correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016 Sep 17. pii: S0304-3940(16)30707.
    PubMed     Text format     Abstract available


  167. MATSUURA K, Maeda M, Tabei KI, Umino M, et al
    A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease.
    Neurosci Lett. 2016 Sep 9. pii: S0304-3940(16)30684.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: